title: Screening for Chlamydia and gonorrhea: U.S. Preventive Services Task Force recommendation statement.
abstract: METHODS
  Update of previous U.S. Preventive Services Task Force (USPSTF) recommendations on screening for chlamydia (2007) and gonorrhea (2005).
  
  
  METHODS
  The USPSTF reviewed the evidence on screening for chlamydial and gonococcal infections in asymptomatic patients from studies published since its last reviews. The USPSTF also considered evidence from its previous recommendations and reviews.
  
  
  METHODS
  This recommendation applies to all sexually active adolescents and adults, including pregnant women.
  
  
  CONCLUSIONS
  The USPSTF recommends screening for chlamydia in sexually active females aged 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF recommends screening for gonorrhea in sexually active females aged 24 years or younger and in older women who are at increased risk for infection. (B recommendation) The USPSTF concludes that the current evidence is insufficient to assess the balance of benefits and harms of screening for chlamydia and gonorrhea in men. (I statement).
authors.forename: Michael L
authors.initials: ML
authors.lastname: LeFevre
mesh_terms: D000293:Adolescent; D000328:Adult; D000900:Anti-Bacterial Agents / Q000627:therapeutic use; D058070:Asymptomatic Diseases; D001431:Bacteriological Techniques; D035843:Biomedical Research; D002690:Chlamydia Infections / Q000175:diagnosis* / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D042241:Early Diagnosis; D005260:Female; D006069:Gonorrhea / Q000175:diagnosis* / Q000188:drug therapy / Q000191:economics / Q000517:prevention & control; D017048:Health Care Costs; D006801:Humans; D008297:Male; D008403:Mass Screening / Q000009:adverse effects; D021141:Nucleic Acid Amplification Techniques; D011247:Pregnancy; D012307:Risk Factors; D014481:United States; D055815:Young Adult
chemical_list: D000900:Anti-Bacterial Agents